Patricia Ganz named editor in chief of Journal of the National Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Patricia Ganz will replace Carmen Allegra as editor-in-chief of JNCI.

This move was precipitated by Allegra’s recent assignment at NCI as the head of gastrointestinal therapeutics of the Clinical Investigations Branch at the Cancer Therapy Evaluation Program. Allegra will continue at JNCI as deputy editor.

Ganz is a professor of health policy and management in the Fielding School of Public Health, and a professor of medicine in the David Geffen School of Medicine at UCLA. She also serves as director of Cancer Prevention & Control Research at UCLA’s Jonsson Comprehensive Cancer Center.

As editor-in-chief, Ganz is responsible for JNCI Monographs, a supplement publication that provides a venue for conference proceedings or topic areas where a series of related articles serve a scientific purpose.

During the past two years, JNCI has developed a series of virtual collections curated from prior publications; these thematically organized collections focus on timely selected topics and are featured online with free access for several months.

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login